Changxin People's Hospital
Changxin People's Hospital
Huzhou, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 24-Week Recurrence Rate of Gout Following Firsekibart Treatment | Gout Flare | Not yet recruiting | Not applicable | 2026-06-04 | NCT07625514 | |
| Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial | Gout Flares | Not yet recruiting | Not applicable | 2026-06-01 | NCT07616531 |